Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study.

doi:10.1093/jjco/hyaf176

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study.

Japanese journal of clinical oncology - 13 Feb 2026

Yokoyama Takanori, Yamamoto Yasuko, Okazawa-Sakai Mika, Yamashita Natsumi, Usami Tomoka, Matsumoto Mihoko, Inui Hiroaki, Nishimura Masato, Tanaka Tamaki, Ushiwaka Takashi, Takehara Kazuhiro

Abstract excerpt

BACKGROUND: To evaluate the current state of hereditary cancer syndrome management in patients with ovarian and endometrial cancer and to identify the barriers to uptake of genetic testing. METHODS: We conducted a cross-sectional multicenter study at five regional cancer centers in Japan, including 229 patients with ovarian cancer and 454 with endometrial cancer treated between January 2021 and December 2022. We...

Read the complete abstract on PubMed